LIST OF RECOMMENDATIONS
Recommendation
3.41 The committee recommends that the government and
industry parties, through the review, continue the examination of issues in
chemotherapy drug pricing to ensure that existing funds under the Fifth
Community Pharmacy Agreement as already agreed are appropriately directed to
reflect the costs and benefits of the supply of chemotherapy drugs, and to
ensure the ongoing supply of these drugs across all services, particularly in
rural and regional areas.
Navigation: Previous Page | Contents | Next Page